SCHEMBL10377014

SCHEMBL10377014

O=Cc1c(OCCCC(=O)N(C2CCCCC2)C2CCCCC2)cccc1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
POLB P06746 2/20 0.39
RAB9A P51151 2/20 0.39
RECQL P46063 2/20 0.39
NPC1 O15118 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
KDM4E B2RXH2 3/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
PDE3B Q13370 2/20 0.38
PDE3A Q14432 2/20 0.38
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7311792 0.90 PDE3B (0.48) MEN1KMT2AKDM4ECYP2C19PDE3B
SCHEMBL10374810 0.87 PDE3B (0.45) SMN1; SMN2MEN1KMT2AKDM4ECYP2D6
SCHEMBL10374568 0.86 PDE3B (0.45) MEN1KMT2AKDM4ECYP2D6CYP2C19
SCHEMBL7318371 0.86 PDE3B (0.45) MEN1KMT2AKDM4ECYP2D6CYP2C19
SCHEMBL7311982 0.85 PDE3B (0.43) SMN1; SMN2POLBRAB9ARECQLNPC1
SCHEMBL10754694 0.85 PDE3B (0.46) SMN1; SMN2POLBMEN1KMT2AGAA
SCHEMBL10375053 0.84 THRA (0.40) SMN1; SMN2POLBRECQLMEN1KMT2A
SCHEMBL10376570 0.83 ALDH1A1 (0.39) SMN1; SMN2MEN1KMT2AGAAKDM4E
SCHEMBL10374992 0.83 PDE3B (0.39) SMN1; SMN2POLBRAB9ARECQLNPC1
SCHEMBL10376587 0.83 L3MBTL1 (0.39) SMN1; SMN2POLBRECQLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0116948-B1 (2-OXO-1,2,3,5-TETRAHYDROIMIDAZO-(2,1-B)QUINAZOLINYL)-OXYALKYL-AMIDES SYNTEX (U.S.A.) INC. (US) 1990-01-03 EP disclosed
US-4663320-A ANTITUMOR AGENTS, ANTICOAGULANTS SYNTEX (U.S.A.) INC. (US) 1987-05-05 US disclosed
US-4551459-A Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides SYNTEX (U.S.A.) INC. (US) 1985-11-05 US disclosed
US-4490371-A ANTICOAGULANTS, PHOSPHODIESTERASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1984-12-25 US disclosed
EP-0116948-A2 (2-Oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)-oxyalkyl-amides SYNTEX (U.S.A.) INC. (US) 1984-08-29 EP disclosed